Related Experiment Video
Updated: Jul 19, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Textbook Oncological Outcome in European GASTRODATA
Katarzyna Sędłak1, Karol Rawicz-Pruszyński1, Radosław Mlak2
1Department of Surgical Oncology, Medical University of Lublin, Lublin, Poland.
Textbook Outcome (TO) was achieved in 68.5% of gastric cancer patients, with neoadjuvant chemotherapy and D2 lymphadenectomy improving results. Textbook Oncological Outcome (TOO) was achieved in 22.8%, highlighting poor chemotherapy adherence.
Area of Science:
- Oncology
- Surgical Quality Assessment
- Gastric Cancer Treatment
Background:
- Textbook Outcome (TO) is a composite parameter for surgical quality, correlating with improved survival in gastric cancer.
- Textbook Oncological Outcome (TOO) was developed as a quality metric for optimal multimodal treatment in locally advanced gastric cancer.
Purpose of the Study:
- To evaluate the rates of Textbook Outcome (TO) and Textbook Oncological Outcome (TOO) in a European gastric cancer patient cohort.
- To identify factors influencing the achievement of TO and TOO in gastric cancer patients.
Main Methods:
- Analysis of 1700 patients from the GASTRODATA registry, assessing criteria for TO and TOO.
- Statistical analysis using logistic regression to determine factors impacting TO and TOO achievement.
Main Results:
- TO was achieved in 68.5% of patients; neoadjuvant chemotherapy and D2/D2+ lymphadenectomy positively impacted TO.
- Older age, advanced tumor stage (pT3/4), higher ASA score (3/4), and total gastrectomy negatively affected TO.
- TOO was achieved in 22.8% of patients; older age, advanced tumor stage, and higher ASA score negatively impacted TOO.
Conclusions:
- Adherence to perioperative chemotherapy guidelines for gastric cancer remains suboptimal despite surgical improvements.
- Future oncologic quality metrics should prioritize perioperative chemotherapy compliance and thorough lymphadenectomy.
More Related Videos
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Related Concept Videos
Cancer Survival Analysis
Treatment Resistant Cancers
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...